Over the last twenty years, many studies have analysed the presence of the SPANX-A/D subfamily in various cancers, such as breast, myeloma, haematological, melanoma, bladder and prostate carcinomas3,8–12, to clarify the function of the protein subfamily in carcinogenesis. Here, SPANXA1 is linked to cancer.